This webinar explains the MDR 2018 - Medical Device MDR following new FDA Guidance
Date2018-01-11
Deadline2018-01-11
Venue9106 Seven Locks Road, Bethesda, Maryland 20817, USA - United States
KeywordsThursday; January 11; 2018; At 13:00 Hrs (EST) 60 Minutes; Http://bit.ly/2DuxNcK
Websitehttps://bit.ly/2jkHyoz
Topics/Call fo Papers
Description :
This webinar explains the MDR regulation considering the new information contained in the Guidance and describes a compliant MDR procedure. Areas covered will include reporting requirements, record keeping requirements, report timing, clarification of the term “becoming aware” and clarification of reporting using form 3500A.
Why :
FDA Medical Device Reporting (MDR) regulations require firms who have received complaints of device malfunctions, serious injuries or deaths associated with medical devices to notify FDA of the incident. MDR is the mechanism for the FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so that they can be detected and corrected quickly. FDA, in November 2016, issued a Guidance explaining and clarifying the existing MDR regulation. Many of the details of the MDR regulation were unclear and ambiguous and resulted in nonconformances. This new Guidance attempts to eliminate confusion by integrating the new Guidance information into the existing regulation. handout is CAPA flow chart
This webinar explains the MDR regulation considering the new information contained in the Guidance and describes a compliant MDR procedure. Areas covered will include reporting requirements, record keeping requirements, report timing, clarification of the term “becoming aware” and clarification of reporting using form 3500A.
Why :
FDA Medical Device Reporting (MDR) regulations require firms who have received complaints of device malfunctions, serious injuries or deaths associated with medical devices to notify FDA of the incident. MDR is the mechanism for the FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so that they can be detected and corrected quickly. FDA, in November 2016, issued a Guidance explaining and clarifying the existing MDR regulation. Many of the details of the MDR regulation were unclear and ambiguous and resulted in nonconformances. This new Guidance attempts to eliminate confusion by integrating the new Guidance information into the existing regulation. handout is CAPA flow chart
Other CFPs
- Medical Device Human Factors Validation Testing Following ISO 62366 and new FDA Guidance
- 2nd International Young Engineers Forum on Electrical and Computer Engineering
- 9th International RAIS Conference on Social Sciences and Humanities
- A Stream on “Mediterranean Studies in Asia”
- A Stream on “Factors That Drive the Real Estate Markets in Europe and Specifically in Greece”
Last modified: 2017-12-30 20:37:05